Epilepsy Animation

Research Study Opens The Door To New Class Of Drugs For Epileptic Seizures
A chemical compound that boosts the action of a molecule normally produced in the brain may provide the starting point for a new line of therapies for the treatment of epileptic seizures, according to a new study by scientists at The Scripps Research Institute...

Certain Epilepsy Drugs May Increase Risk Of Suicide
While the Food and Drug Administration (FDA) requires a warning of an increased risk of suicide for all epilepsy drugs, a new study shows that only certain drugs may increase the risk. The study is published in the July 27, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology...

Women Help Women Live And Cope With Epilepsy In The Family
A new campaign explores the roles and responsibilities women uniquely encounter when living, or caring for a loved one, with epilepsy. "Women Succeeding with Epilepsy" is a collaboration between Epilepsy Advocate and HealthyWomen to educate, empower and inspire women and families whose lives are affected by epilepsy...

FDA Accepts Historical Controls For Epilepsy Monotherapy Studies
New York University researchers revealed that data from previously completed withdrawal to monotherapy studies for antiepileptic drugs (AEDs) provide a valid control for future studies, obviating the need for placebo/pseudo-placebo trials to demonstrate the efficacy of these drugs as monotherapy...

FDA Accepts BANZEL(R) (Rufinamide) Oral Suspension NDA For Review
Eisai Inc. (Headquarters: Woodcliff Lake, NJ; President and CEO: Lonnel Coats), a U.S. subsidiary of Eisai Co., Ltd. (Headquarters: Tokyo; President and CEO: Haruo Naito) announced that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's NDA for BANZEL® (rufinamide) Oral Suspension (40 mg/mL)...

Soldiers With Brain Injuries At Higher Risk Of Epilepsy Decades Later
Soldiers who receive traumatic brain injuries during war may be at a higher risk of epilepsy even decades after the brain injury occurred. The new research is published in the July 20, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology...

Research Project Analyses Cerebral Bioelectricity In Order To Detect Epilepsy
A group of researchers from Universidad Carlos III de Madrid (UC3M) has presented a new algorithm that uses a new method to analyse the information obtained from electroencephalograms to detect neurodegenerative diseases, such as epilepsy, using the bioelectric signals of the brain...

NeuroPace Submits PMA Application For FDA Approval Of Novel Investigational Device For Epilepsy
NeuroPace, Inc. announced that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its RNS® System, a novel investigational device that utilizes responsive neurostimulation to monitor and interrupt abnormal electrical activity in the brain before seizures occur...

Epilepsy Nurses Encouraged To Take The Right Path, UK
A new learning and development pathway programme has been produced for Nurses working at the National Centre for Young People with Epilepsy (NCYPE). The national epilepsy charity has a world class medical centre - the Neville Childhood Epilepsy Centre - as part of its 60 acre campus in Lingfield, Surrey...

New Data For Vimpat (Lacosamide) C-V Showed Sustained Efficacy For Up To 5 Years
New long term data showed that Vimpat® (lacosamide) C-V provided sustained reduction in seizure frequency for up to five years when used as an add-on treatment for uncontrolled partial onset seizures in adults with epilepsy...

Researchers At UH Work To Prevent Neurological Diseases
Many diseases of brain function, such as epilepsy and schizophrenia, are caused by problems in how neurons communicate with each other. A University of Houston (UH) researcher and his team are analyzing these commands and connections in an attempt to prevent those diseases. Dr. Jan-Ake Gustafsson, Robert A...

A Mutation In An Ion Channel That Changes Its Dynamics Is Implicated In Epilepsy
In 2004, Washington University in St. Louis researcher Jianmin Cui was handed a puzzling clue to the structure of an ion channel his lab had been studying for five years...

Sun Pharma Announces USFDA Approval For Generic Keppra(R) Injection
Sun Pharma announced that USFDA has granted an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Keppra® Injection, levetiracetam injection. This generic levetiracetam injection, 100 mg/ml packaged in 500 mg/5 ml single use vials, is equivalent to UCB's Keppra® Injection 100 mg/ml...

Upsher-Smith Laboratories Announces Initiation Of Phase III Clinical Trial Of USL255 (Extended-Release Topiramate)
Upsher-Smith Laboratories, Inc. announced the initiation of a global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults, using the company's proprietary formulation technology...

New Oral Solution Formulation Of Antiepileptic Drug Vimpat (Lacosamide) (C-V)
UCB has announced the availability of an oral solution formulation of Vimpat® (lacosamide) C-V, an antiepileptic drug (AED) for add-on treatment of partial-onset seizures in people with epilepsy age 17 years and older. Vimpat 10 mg/mL solution is now available in U.S. pharmacies...